Dr. Hurt is a physician-executive with deep experience in radiopharmaceutical and oncology drug development. As Chief Medical Officer at OranoMed and Senior Medical Director at Reata Pharmaceuticals, he led the advancement of breakthrough therapies across multiple indications. He earned his Doctor of Medicine from Texas Tech University Health Sciences Center and an MBA from Xavier University. He brings broad experience in clinical development leadership, regulatory strategy, and the specialized operational considerations required for radiopharmaceutical research and development.